Trial intelligence / Profile preview

Pilot randomized double-blind study of Tacalcitol (Bonalfa) in vitiligo vulgaris

2004-003215-22Phase 4Active

Sponsor
Antonio Noda Cabrera
Start
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Vitiligo comparing Tacalcitol (Bonalfa) arm with Placebo arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Nov 2005; status: active.

02

Drugs

tacalcitol
03

Conditions

Vitiligo

Beyond the preview

Go deeper on 2004-003215-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-003215-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call